Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
The Annals of Pharmacotherapy
|
September 6, 2012
An analysis of potentially prolactin-related adverse events and abnormal prolactin values in randomized clinical trials with paliperidone palmitate
Thomas R Einarson, Michiel E H Hemels, Isaac Nuamah, et al.
Journal of Glaucoma
|
December 4, 2003
Cost of glaucoma in Canada: analyses based on visual field and physician's assessment
Michael Iskedjian, John Walker, Colin Vicente, et al.
Journal of Medical Economics
|
November 5, 2015
Systematic review of models used in economic analyses in moderate-to-severe asthma and COPD
Thomas R Einarson, Basil G Bereza, T Anders Nielsen, et al.
Current Medical Research and Opinion
|
May 19, 2005
Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis
John H Walker, Yvonne Buys, Graham Trope, et al.
Journal of Medical Economics
|
July 13, 2013
Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland
Thomas R Einarson, Hanna Pudas, Roman Zilbershtein, et al.
Clinical Therapeutics
|
March 26, 2002
Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis
Michael Iskedjian, Thomas R Einarson, Linda D MacKeigan, et al.
American Journal of Industrial Medicine
|
December 15, 2004
Paternal organic solvent exposure and adverse pregnancy outcomes: a meta-analysis
J Floris S Logman, Laurens E de Vries, Michiel E H Hemels, et al.
The Annals of Pharmacotherapy
|
April 24, 2003
HOPE study impact on ACE inhibitors use
Michiel E H Hemels, Heather A Bennett, Lori Bonari, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 3, 2008
Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies
Richard P Cashin, Philip Lui, Márcio Machado, et al.
Revista De Saude Publica
|
October 7, 2020
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
Maurilio de Souza Cazarim, João Paulo Vilela Rodrigues, Priscila Santos Calcini, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
The Annals of Pharmacotherapy
|
September 6, 2012
An analysis of potentially prolactin-related adverse events and abnormal prolactin values in randomized clinical trials with paliperidone palmitate
Thomas R Einarson, Michiel E H Hemels, Isaac Nuamah, et al.
Journal of Glaucoma
|
December 4, 2003
Cost of glaucoma in Canada: analyses based on visual field and physician's assessment
Michael Iskedjian, John Walker, Colin Vicente, et al.
Journal of Medical Economics
|
November 5, 2015
Systematic review of models used in economic analyses in moderate-to-severe asthma and COPD
Thomas R Einarson, Basil G Bereza, T Anders Nielsen, et al.
Current Medical Research and Opinion
|
May 19, 2005
Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis
John H Walker, Yvonne Buys, Graham Trope, et al.
Journal of Medical Economics
|
July 13, 2013
Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland
Thomas R Einarson, Hanna Pudas, Roman Zilbershtein, et al.
Clinical Therapeutics
|
March 26, 2002
Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis
Michael Iskedjian, Thomas R Einarson, Linda D MacKeigan, et al.
American Journal of Industrial Medicine
|
December 15, 2004
Paternal organic solvent exposure and adverse pregnancy outcomes: a meta-analysis
J Floris S Logman, Laurens E de Vries, Michiel E H Hemels, et al.
The Annals of Pharmacotherapy
|
April 24, 2003
HOPE study impact on ACE inhibitors use
Michiel E H Hemels, Heather A Bennett, Lori Bonari, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 3, 2008
Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies
Richard P Cashin, Philip Lui, Márcio Machado, et al.
Revista De Saude Publica
|
October 7, 2020
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
Maurilio de Souza Cazarim, João Paulo Vilela Rodrigues, Priscila Santos Calcini, et al.
Page
of 13